Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase is a research paper published in New England Journal of Medicine (2021). On theSindex it has a DataRank of 8.3. It has been cited 662 times, with 100 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.975
From this paper's citation signal
Citation Network Contribution
7.3
From 100 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 100 citers.
Biomedical Advanced Research and Development Authority
Grant: contract 75A50120C00034
National Institute of Allergy and Infectious Diseases
Grant: UM1 AI 68614; UM1 AI 68635; UM1 AI 68618;UM1 AI 68
NIAID NIH HHS
Grant: L40 AI154610
NIAID NIH HHS
Grant: UM1 AI068614
NIAID NIH HHS
Grant: UM1 AI068619
NIAID NIH HHS
Grant: UM1 AI148576
NIAID NIH HHS
Grant: UM1 AI068618
NIAID NIH HHS
Grant: UM1 AI148689
NICHD NIH HHS
Grant: K12 HD052892
NIAID NIH HHS
Grant: UM1 AI148575
NIAID NIH HHS
Grant: UM1 AI068636
BLRD VA
Grant: I01 BX003714
NIAID NIH HHS
Grant: UM1 AI068635
NIAID NIH HHS
Grant: UM1 AI148685
NIAID NIH HHS
Grant: K08 AI143923
NIEHS NIH HHS
Grant: P30 ES010126
NIAID NIH HHS
Grant: UM1 AI069424
NIAID NIH HHS
Grant: UM1 AI148373
NIAID NIH HHS
Grant: UM1 AI148684
NIAID NIH HHS
Grant: K23 AI159399
Moderna
MeSH Terms